Apologies. I misunderstood the version history.
In any case . All that matters are the topline results in August.
Trial milestone dates are often changed, I wouldn’t read anything into it unless it’s a significant change.
The 1 year delay until final completion was set at the beginning of the trial, so not related to trial results.
I’m a lot more interested in seeing a phase3 study start than a phase two study finish.
Ann: Immuron CEO to present at Emerging Growth Conference, page-11
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9352 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 251204 | 4 |
View Market Depth
| Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |